Literature DB >> 3139546

In vitro activity of eight antimicrobial agents against non-penicillinase-producing gonococci isolated in Munich.

D Abeck1, A P Johnson, F Alexander, H C Korting, R C Ballard.   

Abstract

The susceptibility of 119 strains of Neisseria gonorrhoeae isolated in Munich in 1986 to eight antibiotics was assessed. Although some degree of resistance to penicillin and tetracycline, as well as high minimum inhibitory concentrations (MIC) of spectinomycin, were observed, all the strains were sensitive to ciprofloxacin, enoxacin, fleroxacin, cefotaxime, and FCE 22250.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3139546      PMCID： PMC1194222          DOI： 10.1136/sti.64.4.233

Source DB:  PubMed          Journal:  Genitourin Med        ISSN： 0266-4348


  5 in total

1.  Gonococcal resistance to antibiotics.

Authors:  C S Easmon
Journal:  J Antimicrob Chemother       Date:  1985-10       Impact factor: 5.790

2.  Characterisation of penicillinase producing gonococci isolated in Munich, 1981-6.

Authors:  D Abeck; A P Johnson; H C Korting
Journal:  Genitourin Med       Date:  1988-02

3.  Chromosomal resistance of gonococci to antibiotics.

Authors:  C A Ison; J Gedney; C S Easmon
Journal:  Genitourin Med       Date:  1987-08

4.  A laboratory assessment of ciprofloxacin and comparable antimicrobial agents.

Authors:  L Shrire; J Saunders; R Traynor; H J Koornhof
Journal:  Eur J Clin Microbiol       Date:  1984-08       Impact factor: 3.267

5.  In vitro activity of selected antimicrobial agents against penicillinase producing Neisseria gonorrhoeae (PPNG) and non-PPNG strains.

Authors:  D J Waghorn; B S Azadian; C Talboys
Journal:  Genitourin Med       Date:  1986-12
  5 in total
  5 in total

1.  Plasmid content, serotypes, and antimicrobial susceptibility of Neisseria gonorrhoeae strains isolated in Munich in 1987-88.

Authors:  D Abeck; A P Johnson; W Grimm; R Zaba; H C Korting
Journal:  Eur J Epidemiol       Date:  1989-06       Impact factor: 8.082

Review 2.  Enoxacin: a reappraisal of its clinical efficacy in the treatment of genitourinary tract infections.

Authors:  S S Patel; C M Spencer
Journal:  Drugs       Date:  1996-01       Impact factor: 9.546

Review 3.  Fleroxacin clinical pharmacokinetics.

Authors:  A E Stuck; D K Kim; F J Frey
Journal:  Clin Pharmacokinet       Date:  1992-02       Impact factor: 6.447

4.  [In-vitro activity of enoxacin: a multicenter study].

Authors:  B Wiedemann; D Adam; A Bauernfeind; C Blasius; I Braveny; F Daschner; H Grimm; H Hahn; H Langmaack; F Ley
Journal:  Infection       Date:  1989       Impact factor: 3.553

Review 5.  Fleroxacin. A review of its pharmacology and therapeutic efficacy in various infections.

Authors:  J A Balfour; P A Todd; D H Peters
Journal:  Drugs       Date:  1995-05       Impact factor: 9.546
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.